Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Misumi

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|March 1, 1992
[Angiographic studies of atherosclerotic changes in coronary vein grafts after operation]S Suzuki, H Kumamaru, T Ariizumi, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|February 1, 1984
[Histological classification and prognosis of mammary cancer-histological classification devised by the Japan Mammary Cancer Society and WHO classification]S Takashima, T Misumi, J Yoshizawa, et al.
ESMO Open|November 28, 2023
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational studyY Narita, T Matsushima, Y Sakamoto, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Cancer registry as external control data for regulatory submission in JapanH Bando, N Okita, Y Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The emerging role of real-world data in oncology care in JapanH Bando, E Tajima, Y Aoyagi, et al.
ESMO Open|December 12, 2022
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)W Okamoto, K Sakai, A Makiyama, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai|March 1, 1992
[Angiographic studies of atherosclerotic changes in coronary vein grafts after operation]S Suzuki, H Kumamaru, T Ariizumi, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics|February 1, 1984
[Histological classification and prognosis of mammary cancer-histological classification devised by the Japan Mammary Cancer Society and WHO classification]S Takashima, T Misumi, J Yoshizawa, et al.
ESMO Open|November 28, 2023
Chemotherapy after nivolumab for advanced gastric cancer (REVIVE): a prospective observational studyY Narita, T Matsushima, Y Sakamoto, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Cancer registry as external control data for regulatory submission in JapanH Bando, N Okita, Y Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The emerging role of real-world data in oncology care in JapanH Bando, E Tajima, Y Aoyagi, et al.
ESMO Open|December 12, 2022
A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)W Okamoto, K Sakai, A Makiyama, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
Pageof 3